Rotterdam media company providing science communication and dissemination support to European pharmaceutical research training networks.
24 Media Labs is a Rotterdam-based private company that provides media production, science communication, and digital content services. In H2020 research networks, they contributed as a third-party collaborator — most likely offering science communication training, multimedia production, or dissemination services to PhD researchers in European Training Networks. Their participation in two MSCA Innovative Training Networks focused on drug discovery suggests they specialize in making complex scientific content accessible to professional audiences. As a non-academic partner in these consortia, their practical value lay in bridging laboratory research and public or professional communication.
Contributed as third party to both ONCORNET and FRAGNET MSCA-ITN networks, where non-academic partners typically deliver media skills and science communication training to early-stage researchers.
Both ONCORNET (oncogenic receptor research) and FRAGNET (fragment-based drug discovery) are pharmaceutical training networks requiring professional dissemination and outreach support.
MSCA-ITN third-party partners are specifically used to expose doctoral researchers to non-academic working environments, a role 24 Media Labs fulfilled in both ONCORNET and FRAGNET.
Both H2020 participations fall within a narrow two-year window (2015–2016) and share the same project type — MSCA European Training Networks in pharmaceutical drug discovery. No evolution in focus is observable across the two projects, nor is any keyword shift detectable in the available data. With no H2020 activity recorded after 2016, it is not possible to determine whether the organization's direction changed in later years.
With only two third-party appearances in 2015–2016 and no subsequent H2020 activity, no directional trend can be reliably identified — the organization may have reduced or exited EU project participation after this period.
24 Media Labs has participated exclusively as a third party in every H2020 project — the most peripheral role in an EU consortium, typically meaning they provided in-kind contributions such as hosting, workshops, or dissemination services without receiving direct EC funding. They have never coordinated or led a project. The 26 partners across 9 countries in their network reflect the breadth of the large MSCA training consortia they joined, not independent relationships they originated.
24 Media Labs has indirect exposure to 26 unique consortium partners across 9 European countries, entirely through third-party involvement in two large MSCA-ITN networks. This breadth reflects the consortia they joined rather than partnerships they built directly.
As a media company with a footprint in pharmaceutical research training networks, 24 Media Labs occupies a niche few pure-research or pure-media firms fill — specifically, the non-academic partner slot in MSCA consortia that requires professional dissemination and communication expertise. For future MSCA training network builders seeking a Dutch media partner with life sciences experience, they offer a verified track record, albeit a narrow one. Any collaboration should verify their current media capabilities and active engagement, as their recorded H2020 activity ended in 2016.
